NDC 0078-0664
UTIBRON NEOHALER
Indacaterol And Glycopyrrolate
UTIBRON NEOHALER is a Respiratory (inhalation) Capsule in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Indacaterol Maleate; Glycopyrrolate.
| Product ID | 0078-0664_77de1b47-3665-4fb2-b7a5-31dcbcd63622 |
| NDC | 0078-0664 |
| Product Type | Human Prescription Drug |
| Proprietary Name | UTIBRON NEOHALER |
| Generic Name | Indacaterol And Glycopyrrolate |
| Dosage Form | Capsule |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2015-10-29 |
| Marketing End Date | 2019-06-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207930 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | INDACATEROL MALEATE; GLYCOPYRROLATE |
| Active Ingredient Strength | 28 ug/1; ug/1 |
| Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| NDC Exclude Flag | N |